Latest Corporate News

The Pharmascience Team met the Enbridge Ride to Conquer Cancer Challenge and raised funds to advance cancer research

 

Pharmascience Inc launches (Pr)pms-TRANDOLAPRIL, first generic bioequivalent to (Pr)MAVIK available on the market, for the treatment of mild to moderate essential hypertension

 

Successful FDA Inspection of our Bioanalytical Laboratory